Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
EF ›
EFERMIA
Trademark search for:
EFERMIA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-05-16 — Application filed
2019-06-27 — Sn assigned for sect 66a appl from ib
2019-06-28 — Application filed
2019-07-02 — Application filed
2019-07-04 — Assigned to examiner
2019-07-05 — Final disposition recorded
2019-07-06 — Office action issued
2019-07-27 — Office action issued
2019-07-27 — Office action issued
2019-08-16 — Office action issued
2019-09-23 — Teas/email correspondence entered
2019-09-23 — Office action issued
2019-09-23 — Correspondence received in law office
2019-09-24 — Approved for pub - principal register
2019-09-30 — Assigned to lie
2019-10-16 — Notification of possible opposition sent to ib
2019-10-16 — Notification of notice of publication e-mailed
2019-10-16 — Notice of start of opposition period created, to be sent to ib
2019-11-02 — Notification processed by ib
2019-11-05 — Published for opposition
2019-11-05 — Official gazette publication confirmation e-mailed
2019-11-22 — Limitation of goods received from ib
2020-01-21 — Registered-principal register
2020-03-17 — Case assigned to post registration paralegal
2020-03-17 — Correction under section 7 - processed
2020-03-17 — Limitation from the ib examined and entered
2020-03-26 — Final status recorded
2020-04-09 — Death of international registration
2020-04-10 — Notification of effect of cancellation of intl reg mailed
2020-04-12 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Glaxo Group Limited
GB
Glaxo Group Limited
GB
Glaxo Group Limited
GB
Correspondent
Merilee J. Arevalo GSK 5 MOORE DRIVE LBP, 5.5A RESEARCH TRIANGLE PARK, NC 27709-3398
Filing Details
Filing Date:
2019-05-16
Status Date:
2020-03-26
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.